Fresenius Medical Care AG (FMS): Price and Financial Metrics


Fresenius Medical Care AG (FMS)

Today's Latest Price: $42.49 USD

0.13 (0.31%)

Updated Jul 10 6:30pm

Add FMS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 67 in Medical - Services

See all "A" rated Strong Buy stocks

FMS Stock Summary

  • FMS has a market capitalization of $25,352,019,410 -- more than approximately 92.71% of US stocks.
  • With a year-over-year growth in debt of 60.79%, Fresenius Medical Care AG & Co KGaA's debt growth rate surpasses 82.53% of about US stocks.
  • In terms of volatility of its share price, FMS is more volatile than merely 6.7% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Fresenius Medical Care AG & Co KGaA are ADM, MKC, TSN, NTR, and CRH.
  • Visit FMS's SEC page to see the company's official filings. To visit the company's web site, go to www.freseniusmedicalcare.com.
FMS Daily Price Range
FMS 52-Week Price Range

FMS Stock Price Chart Technical Analysis Charts


FMS Price/Volume Stats

Current price $42.49 52-week high $44.47
Prev. close $42.36 52-week low $29.17
Day low $42.06 Volume 147,434
Day high $42.57 Avg. volume 362,633
50-day MA $41.68 Dividend yield 1.06%
200-day MA $37.51 Market Cap 25.35B

Fresenius Medical Care AG (FMS) Company Bio


Fresenius Medical Care provides dialysis care services related to the dialysis treatment a patient receives with end stage renal disease, and other health care services. The company was founded in 1996 and is based in Bad Homburg, Germany.

FMS Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$42.49$92.7115%

Below please find a table outlining a discounted cash flow forecast for FMS, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Fresenius Medical Care AG & Co KGaA ranked in the 63th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Fresenius Medical Care AG & Co KGaA, consider:

  • The company's balance sheet shows it gets 48% of its capital from equity, and 52% of its capital from debt. Notably, its equity weight is greater than merely 14.73% of US equities in the Healthcare sector yielding a positive free cash flow.
  • Fresenius Medical Care AG & Co KGaA's weighted average cost of capital (WACC) is 6%; for context, that number is higher than only 3.11% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%111%
1%113%
2%115%
3%117%
4%119%
5%122%

RSCF, AMPH, DVA, EGRX, and CHE can be thought of as valuation peers to FMS, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


FMS Latest News Stream


Event/TimeNews Detail
Loading, please wait...

FMS Latest Social Stream


Loading social stream, please wait...

View Full FMS Social Stream

Latest FMS News From Around the Web

Below are the latest news stories about Fresenius Medical Care AG & Co KGaA that investors may wish to consider to help them evaluate FMS as an investment opportunity.

Hedge Funds Are Souring On Fresenius Medical Care AG & Co. KGaA (FMS)

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]

Yahoo | July 6, 2020

Fresenius Medical Care: A Solid 2020 Will See Share Price Recapture 2018 Highs

Investment Thesis Fresenius Medical Care 5-year share price performance. Source: TradingView. Fresenius Medical Care (FMS) has a commanding ~38% share of the US Kidney Dialysis clinic treatment market from which it derives ~80% of its revenues, with medical product sales generating the other 20%. Over the past 3 years, the...

Edmund Ingham on Seeking Alpha | July 1, 2020

Fresenius Medical Care (FMS) Presents At Goldman Sachs Global Healthcare Conference - Slideshow

The following slide deck was published by Fresenius Medical Care AG & Co. KGaA in conjunction with this event....

SA Transcripts on Seeking Alpha | June 16, 2020

RBC Capital Sticks to Their Hold Rating for Fresenius Medical Care Corp.

RBC Capital analyst Frank Morgan maintained a Hold rating on Fresenius Medical Care (NYSE:FMS) Corp. on Thursday, setting a price target of $42, which is approximately 6.90% above the present share price of $39.29.

Yahoo | May 18, 2020

Is Fresenius Medical Care AG & Co. KGaA (ETR:FME) A Smart Pick For Income Investors?

Is Fresenius Medical Care AG & Co. KGaA (ETR:FME) a good dividend stock? How can we tell? Dividend paying companies...

Yahoo | May 16, 2020

Read More 'FMS' Stories Here

FMS Price Returns

1-mo 1.31%
3-mo 22.27%
6-mo 13.46%
1-year 8.06%
3-year -10.98%
5-year 1.85%
YTD 15.37%
2019 15.01%
2018 -37.85%
2017 25.49%
2016 1.62%
2015 13.81%

FMS Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full FMS Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9139 seconds.